What does Relay Therapeutics, Inc. (RLAY) do?

Relay Therapeutics, Inc. (RLAY) is a publicly traded company.

What sector does RLAY operate in?

Relay Therapeutics, Inc. operates in the equity market. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find research and analysis for RLAY?

AlphaOS provides AI-assisted research, earnings transcripts, SEC filing analysis, opportunity scoring, and knowledge-graph relationships for Relay Therapeutics, Inc. (RLAY). All content is for research and education — not investment advice.

Relay Therapeutics, Inc. (RLAY)

US equity research on AlphaOS

Relay Therapeutics, Inc. operates in unknown sector.

Relay Therapeutics, Inc. key market context on AlphaOS includes Market capitalization: $3.05B; Recent price: $15.89. Figures update as market data and SEC filings are ingested.

Use this RLAY research hub for earnings transcripts, SEC filings, opportunity scoring, news, and knowledge-graph relationships. Content is for research and education only — not investment advice.

Key facts

Market cap:: $3.05B
Revenue:: $15.36M

Interactive charts, filings, and live quotes load below. Research & analysis only — not investment advice.

Intelligence coverage: 50%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

RLAY

Relay Therapeutics, Inc.

$15.90Jun 18, 2026

AI confidence 62% · prior close shown (market closed)

Filing insights

Loading SEC filing intelligence…

SEC filings

10-K, 10-Q, 8-K, 20-F, 6-K from EDGAR — HTML & PDF stored in GCS

No filings yet

Ingest recent SEC filings for RLAY to enable RAG search and AI risk analysis.

Opening stock page...

Fetching company snapshot, pricing, and intelligence.